Pulmonary hypertension: a contemporary review

S Johnson, N Sommer, K Cox-Flaherty… - American journal of …, 2023 - atsjournals.org
Major advances in pulmonary arterial hypertension, pulmonary hypertension (PH)
associated with lung disease, and chronic thromboembolic PH cast new light on the …

[HTML][HTML] Pathophysiology and new advances in pulmonary hypertension

S Bousseau, RS Fais, S Gu, A Frump, T Lahm - BMJ medicine, 2023 - ncbi.nlm.nih.gov
Pulmonary hypertension is a progressive and often fatal cardiopulmonary condition
characterised by increased pulmonary arterial pressure, structural changes in the pulmonary …

Role of macrophages in pulmonary arterial hypertension

MQ Zhang, CC Wang, XB Pang, JZ Shi, HR Li… - Frontiers in …, 2023 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a severe cardiopulmonary vascular disease
characterized by progressive pulmonary artery pressure elevation, increased pulmonary …

Pathology and pathobiology of pulmonary hypertension: current insights and future directions

C Guignabert, J Aman, S Bonnet… - European …, 2024 - publications.ersnet.org
In recent years, major advances have been made in the understanding of the cellular and
molecular mechanisms driving pulmonary vascular remodelling in various forms of …

CaCl2 treatment effectively delays postharvest senescence of passion fruit

H Xu, P Qiao, J Pan, Z Qin, X Li, HE Khoo, X Dong - Food Chemistry, 2023 - Elsevier
This study aimed to systematically investigate the changes in peel color, physicochemical
characteristics, textural properties, and peel ultrastructure between CaCl 2-treated and water …

Experimental animal models of pulmonary hypertension: Development and challenges

XH Wu, JL Ma, D Ding, YJ Ma, YP Wei… - Animal Models and …, 2022 - Wiley Online Library
Pulmonary hypertension (PH) is clinically divided into 5 major types, characterized by
elevation in pulmonary arterial pressure (PAP) and pulmonary vascular resistance (PVR) …

Epigenetic regulation of programmed cell death in hypoxia-induced pulmonary arterial hypertension

Y Jiang, S Song, J Liu, L Zhang, X Guo, J Lu… - Frontiers in …, 2023 - frontiersin.org
Pulmonary arterial hypertension (PAH) is a severe progressive disease that may cause early
right ventricular failure and eventual cardiac failure. The pathogenesis of PAH involves …

Cornuside is a potential agent against Alzheimer's disease via orchestration of reactive astrocytes

JZ Shi, XM Zheng, YF Zhou, LY Yun, DM Luo, JJ Hao… - Nutrients, 2022 - mdpi.com
Cornuside is an iridoid glycoside from Cornus officinalis, with the activities of anti-
inflammatory, antioxidant, anti-mitochondrial dysfunction, and neuroprotection. In the …

[HTML][HTML] PRDX6-mediated pulmonary artery endothelial cell ferroptosis contributes to monocrotaline-induced pulmonary hypertension

J Liao, SS Xie, Y Deng, D Wu, H Meng, W Lan… - Microvascular …, 2023 - Elsevier
Background Pulmonary hypertension (PH) is a life-threatening cardiopulmonary disorder
whose underlying pathogenesis is unknown. Our previous study showed that pulmonary …

Circular RNAs in pulmonary hypertension: emerging biological concepts and potential mechanism

Q Wang, Y Sun, Q Zhao, W Wu, L Wang… - Animal Models and …, 2022 - Wiley Online Library
Circular RNAs (circRNAs) are endogenous RNAs with a covalently closed single‐stranded
transcript. They are a novel class of genomic regulators that are linked to many important …